Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a ...

A new therapy support group at Jefferson Moss-Magee Rehabilitation helps patients regain independence and identity with ...

British ‘anti-vaxxer’ Paloma Shemirani, 23, died from cancer after refusing chemotherapy for non-Hodgkin lymphoma, according ...

AstraZeneca's (AZN) revenue hit a record high in the second quarter, driven by cancer drug sales and growth in the US market.

PALOMA Shemirani, who died after refusing treatment for her “treatable” cancer, told a court she was “anti-vax”, an inquest ...

TytoCare, a leading Israeli telemedicine company based in Netanya, is willing to work with Vietnamese regulators, insurers, ...

Key Points - GAAP revenue reached $0.85 million in Q2 2025, exceeding analyst estimates and Revenue more than doubled compared to Q2 2024, also exceeding analyst estimates. GAAP loss per share ...

Sound more like science fiction than actual science? Then, brace yourself because there are, at least, 15 breast cancer vaccine clinical trials in various stages in the U.S., some in phase II and III.

Cambridge graduate and model Paloma Shemirani died last July after refusing conventional cancer treatments for her treatable non-Hodgkin lymphoma, a form of blood cancer .

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

Paloma Shemirani, 23, died at Royal Sussex County Hospital on July 24 2024, after declining the treatment for non-Hodgkin ...

This strategy is part of a growing trend in immunotherapy that focuses not just on guiding immune responses, but on upgrading the cells themselves — enhancing their efficiency from within.